.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Covington
Colorcon
US Department of Justice
Moodys
Boehringer Ingelheim
Cipla
Accenture
Cantor Fitzgerald
Cerilliant

Generated: February 21, 2018

DrugPatentWatch Database Preview

Mechanism of Action: UGT2B7 Inhibitors

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms CorpPROMACTAeltrombopag olamineTABLET;ORAL022291-004Oct 20, 2011RXYesNo➤ Sign Up➤ Sign UpY➤ Sign Up
Novartis Pharms CorpPROMACTAeltrombopag olamineTABLET;ORAL022291-001Nov 20, 2008RXYesNo➤ Sign Up➤ Sign UpY➤ Sign Up
Novartis Pharms CorpPROMACTAeltrombopag olamineTABLET;ORAL022291-005Nov 16, 2012RXYesYes➤ Sign Up➤ Sign UpY➤ Sign Up
Novartis Pharms CorpPROMACTAeltrombopag olamineTABLET;ORAL022291-002Nov 20, 2008RXYesNo➤ Sign Up➤ Sign UpY➤ Sign Up
Novartis Pharms CorpPROMACTAeltrombopag olamineTABLET;ORAL022291-003Sep 8, 2009RXYesYes➤ Sign Up➤ Sign UpY➤ Sign Up
Novartis Pharms CorpPROMACTAeltrombopag olamineTABLET;ORAL022291-004Oct 20, 2011RXYesNo➤ Sign Up➤ Sign UpY➤ Sign Up
Novartis Pharms CorpPROMACTAeltrombopag olamineTABLET;ORAL022291-004Oct 20, 2011RXYesNo➤ Sign Up➤ Sign Up➤ Sign Up
Novartis Pharms CorpPROMACTAeltrombopag olamineTABLET;ORAL022291-003Sep 8, 2009RXYesYes➤ Sign Up➤ Sign UpY➤ Sign Up
Novartis Pharms CorpPROMACTAeltrombopag olamineTABLET;ORAL022291-005Nov 16, 2012RXYesYes➤ Sign Up➤ Sign Up➤ Sign Up
Novartis Pharms CorpPROMACTAeltrombopag olamineTABLET;ORAL022291-001Nov 20, 2008RXYesNo➤ Sign Up➤ Sign Up➤ Sign Up
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Dow
Fish and Richardson
Citi
Chubb
Accenture
Express Scripts
Merck
McKinsey
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot